Grifols Total Assets 2012-2019 | GRFS

Grifols total assets from 2012 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Grifols total assets for the quarter ending March 31, 2019 were $13.636B, a 27.7% increase year-over-year.
  • Grifols total assets for 2018 were $14.735B, a 19.38% increase from 2017.
  • Grifols total assets for 2017 were $12.343B, a 10.11% increase from 2016.
  • Grifols total assets for 2016 were $11.21B, a 5.14% increase from 2015.
Grifols Annual Total Assets
(Millions of US $)
2018 $14,735
2017 $12,343
2016 $11,210
2015 $10,662
2014 $11,232
2013 $7,759
2012 $7,237
2011 $8,089
Grifols Quarterly Total Assets
(Millions of US $)
Q2 2018 $13,636
Q2 2017 $12,228
Q1 2017 $12,478
Q4 2016 $11,210
Q3 2016 $10,678
Q2 2016 $10,776
Q1 2016 $10,193
Q4 2015 $10,662
Q3 2015 $10,212
Q2 2015 $10,061
Q1 2015 $10,582
Q4 2014 $11,232
Q3 2014 $10,752
Q2 2014 $9,981
Q1 2014 $9,857
Q4 2013 $7,759
Q3 2013 $7,566
Q2 2013 $7,634
Q1 2013 $7,641
Q4 2012 $7,237
Q3 2012 $7,305
Q2 2012 $7,598
Q1 2012 $7,267
Q4 2011 $8,089
Q3 2011 $7,769
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.442B $5.299B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $53.040B 33.89
Takeda Pharmaceutical (TAK) Japan $26.669B 7.83
Sage Therapeutics (SAGE) United States $9.195B 0.00
Ionis Pharmaceuticals (IONS) United States $9.083B 19.86
Neurocrine Biosciences (NBIX) United States $7.853B 0.00
Catalent (CTLT) United States $7.369B 29.57
Jazz Pharmaceuticals (JAZZ) Ireland $7.311B 10.02
Nektar Therapeutics (NKTR) United States $5.874B 9.57
Tilray (TLRY) Canada $3.929B 0.00
FibroGen (FGEN) United States $3.705B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.481B 12.21
United Therapeutics (UTHR) United States $3.443B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.508B 377.86
PTC Therapeutics (PTCT) United States $2.359B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.061B 7.42
Portola Pharmaceuticals (PTLA) United States $1.848B 0.00
Xencor (XNCR) United States $1.834B 50.08
Tricida (TCDA) United States $1.821B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.767B 85.56
Enanta Pharmaceuticals (ENTA) United States $1.753B 23.96
Zogenix (ZGNX) United States $1.711B 0.00
USANA Health Sciences (USNA) United States $1.687B 14.66
Ironwood Pharmaceuticals (IRWD) United States $1.645B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.552B 0.00
Aerie Pharmaceuticals (AERI) United States $1.529B 0.00
Heron Therapeutics (HRTX) United States $1.446B 0.00
Esperion Therapeutics (ESPR) United States $1.381B 0.00
Turning Point Therapeutics (TPTX) United States $1.330B 0.00
Corcept Therapeutics (CORT) United States $1.191B 17.00
Radius Health (RDUS) United States $1.090B 0.00
ArQule (ARQL) United States $1.047B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.937B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.917B 0.00
Endo (ENDP) Ireland $0.884B 1.42
Odonate Therapeutics (ODT) United States $0.723B 0.00
Aptorum Group (APM) China $0.688B 0.00
CannTrust Holdings (CTST) Canada $0.683B 0.00
Organogenesis Holdings (ORGO) United States $0.676B 0.00
TherapeuticsMD (TXMD) United States $0.642B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.581B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.550B 0.00
Dermira (DERM) United States $0.532B 0.00
Akebia Therapeutics (AKBA) United States $0.522B 0.00
Translate Bio (TBIO) United States $0.513B 0.00
ChemoCentryx (CCXI) United States $0.510B 0.00
GlycoMimetics (GLYC) United States $0.484B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.459B 0.00
Siga Technologies (SIGA) United States $0.449B 1.06
Flexion Therapeutics (FLXN) United States $0.441B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.422B 21.29
BioCryst Pharmaceuticals (BCRX) United States $0.398B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.391B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.373B 0.00
Collegium Pharmaceutical (COLL) United States $0.372B 0.00
Karyopharm Therapeutics (KPTI) United States $0.365B 0.00
KalVista Pharmaceuticals (KALV) United States $0.358B 0.00
TCR2 Therapeutics (TCRR) United States $0.350B 0.00
Forty Seven (FTSV) United States $0.348B 0.00
ImmunoGen (IMGN) United States $0.323B 0.00
Rafael Holdings (RFL) United States $0.304B 0.00
CASI Pharmaceuticals (CASI) United States $0.300B 0.00
Harpoon Therapeutics (HARP) United States $0.292B 0.00
Xeris Pharmaceuticals (XERS) United States $0.281B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.280B 0.00
Molecular Templates (MTEM) United States $0.276B 0.00
OptiNose (OPTN) United States $0.272B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.268B 0.00
Concert Pharmaceuticals (CNCE) United States $0.262B 0.00
Dova Pharmaceuticals (DOVA) United States $0.254B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.239B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.233B 0.00
Aratana Therapeutics (PETX) United States $0.232B 0.00
Calithera Biosciences (CALA) United States $0.228B 0.00
Lannett Co Inc (LCI) United States $0.208B 2.02
Recro Pharma (REPH) United States $0.207B 0.00
Aclaris Therapeutics (ACRS) United States $0.202B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.193B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.185B 0.00
Aldeyra Therapeutics (ALDX) United States $0.183B 0.00
IMV INC (IMV) Canada $0.181B 0.00
Ocular Therapeutix (OCUL) United States $0.180B 0.00
Bio Blast Pharma (ENLV) Israel $0.180B 0.00
MEI Pharma (MEIP) United States $0.177B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.174B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 56.38
Opexa Therapeutics (ACER) United States $0.171B 0.00
Minerva Neurosciences (NERV) United States $0.171B 0.00
Galectin Therapeutics (GALT) United States $0.171B 0.00
Jounce Therapeutics (JNCE) United States $0.167B 0.00
Redhill Biopharma (RDHL) Israel $0.161B 0.00
Ardelyx (ARDX) United States $0.156B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.152B 0.00
Majesco Entertainment (PTE) United States $0.151B 0.00
Neon Therapeutics (NTGN) United States $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.132B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.119B 0.00
AgeX Therapeutics (AGE) United States $0.117B 0.00
Tyme Technologies (TYME) United States $0.116B 0.00
Aquestive Therapeutics (AQST) United States $0.114B 0.00
Champions Oncology (CSBR) United States $0.102B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.102B 0.00
MediWound (MDWD) Israel $0.102B 0.00
Iterum Therapeutics (ITRM) Ireland $0.099B 0.00
Avenue Therapeutics (ATXI) United States $0.098B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 68.53
Natural Alternatives (NAII) United States $0.091B 9.14
Infinity Pharmaceuticals (INFI) United States $0.091B 0.00
Cardiome Pharma (CORV) Canada $0.089B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.088B 0.00
Capnia (SLNO) United States $0.088B 0.00
Mast Therapeutics (SVRA) United States $0.085B 0.00
Nivalis Therapeutics (ALPN) United States $0.084B 0.00
DURECT (DRRX) United States $0.083B 0.00
China SXT Pharmaceuticals (SXTC) China $0.081B 0.00
Adherex Technologies (FENC) United States $0.080B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Genocea Biosciences (GNCA) United States $0.076B 0.00
Novan (NOVN) United States $0.071B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
Neos Therapeutics (NEOS) United States $0.068B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.067B 0.00
ElectroCore (ECOR) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.054B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Zafgen (ZFGN) United States $0.052B 0.00
ProNAi Therapeutics (SRRA) Canada $0.051B 0.00
KemPharm (KMPH) United States $0.048B 0.00
India Globalization Capital (IGC) United States $0.047B 0.00
AIT Therapeutics (AITB) Israel $0.047B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Lipocine (LPCN) United States $0.043B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Bio-Path Holdings (BPTH) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.038B 0.00
ContraFect (CFRX) United States $0.037B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
PharmAthene (ALT) United States $0.033B 0.00
IsoRay (ISR) United States $0.029B 0.00
Heat Biologics (HTBX) United States $0.026B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.022B 0.00
Biomerica (BMRA) United States $0.021B 0.00
Pain Therapeutics (SAVA) United States $0.020B 0.00
Onconova Therapeutics (ONTX) United States $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.019B 1.56
PRECISION THERAPEUTICS INC (POAI) United States $0.018B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Achieve Life Sciences (ACHV) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.015B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.015B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.78
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00